North America Veterinary Healthcare Market Analysis and Forecast by Size, Share, Growth, Trends 2031

The North America Veterinary Healthcare Market size is expected to reach US$ 64,615.4 Million by 2031 from US$ 37,968.7 Million in 2024. The market is estimated to record a CAGR of 8.0% from 2025 to 2031.

Executive Summary and North America Veterinary Healthcare Market Analysis:

The veterinary healthcare market in North America is segmented into the US, Canada, and Mexico. The US holds the largest market share, followed by Canada. The demand for veterinary healthcare in the region is fueled by the increasing government support to provide cost-effective healthcare services and the rising strategic developments by the veterinary healthcare players such as Elanco, Zoetis Inc., and Boehringer Ingelheim Animal Health USA, Inc. to enhance veterinary products. A growing healthcare industry that demands frameworks and guidelines based on real-world data for their business models contributes to this market.

North America Veterinary Healthcare Market: Strategic Insights

North America Veterinary Healthcare Market Segmentation Analysis:

• By Animal Type, the North America Veterinary Healthcare Market is segmented into Companion and Livestock and Poultry. Livestock and Poultry held the largest share of the market in 2024.
• By Companion Animal Type, the North America Veterinary Healthcare Market is segmented into Dog, Cats, and Others. Dog held the largest share of the market in 2024.
• By Livestock and Poultry, the North America Veterinary Healthcare Market is segmented into Poultry, Equine, Bovine, and Others. Poultry held the largest share of the market in 2024.
• By Product Type, the North America Veterinary Healthcare Market is segmented into Pharmaceuticals, Medical Devices, and Feed Additives. Pharmaceuticals held the largest share of the market in 2024.
• By Pharmaceuticals Products, the North America Veterinary Healthcare Market is segmented into Antimicrobials, Parasiticides, Vaccines, and Others. Others held the largest share of the market in 2024.
• By End User, the North America Veterinary Healthcare Market is segmented into Veterinary Hospitals, Clinics, and Others. Veterinary Hospitals held the largest share of the market in 2024.

North America Veterinary Healthcare Market Players Density: Understanding Its Impact on Business Dynamics

The North America Veterinary Healthcare Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

North America Veterinary Healthcare Market Outlook

Zoonotic diseases, which spread from animals to humans, are caused by viruses, bacteria, parasites, and fungi and lead to illnesses that can range from mild to severe and potentially even cause death. According to an article published by the Center for Disease Control (CDC) in February 2024, over 60% of infectious diseases in humans can be transmitted from animals, and 75% of emerging infectious diseases in humans originate from animals. Each year, zoonotic diseases cause 2.5 billion human infections and 2.7 million deaths worldwide. According to the World Organization for Animal Health (WOAH), about 60% of pathogens causing human diseases come from domestic animals or wildlife, and 80% of bioterrorism-related pathogens originate from animals. Common zoonotic diseases include Ebola, rabies, salmonella, anthrax, Lyme disease, E. coli, and bird flu. HIV originated as a zoonosis before mutating into human-only strains. As per the World Health Organization (WHO), animal diseases lead to over 20% of global production losses in livestock, threatening the livelihoods of rural communities dependent on animal agriculture. The increasing incidences of zoonotic diseases are propelling the demand for preventive measures, including vaccinations and diagnostic tests which is driving the emphasis on animal healthcare products and services, as pet owners and farmers aim to protect their animals and, in turn, safeguard human health. Efforts to manage and treat zoonotic diseases have fueled the development of new medications and treatments. This expansion in treatment options contributes to market growth as companies invest in research and development to address these health challenges.

North America Veterinary Healthcare Market Country Insights

By country, the North America Veterinary Healthcare Market is segmented into the United States, Canada, and Mexico. The United States held the largest share in 2024.

The increasing pet ownership is driving the demand for veterinary medications and vaccines for companion animals in the country. According to the 2023-2024 American Pet Products Association Survey, 66% of US households, which equates to 86.9 million households, own a pet. The rising product approvals by the US Food and Drug Administration (FDA) further contribute to the demand. In September 2024, the US FDA approved Zenrelia, a safe, effective, and convenient once-daily oral JAK inhibitor for the control of pruritus (itching) associated with allergic dermatitis and control of atopic dermatitis in dogs.

In October 2023, Zoetis launched 2 FDA approved drugs in the US veterinary market. The FDA approved bedinvetmab injection (Librela; Zoetis) to help control pain associated with osteoarthritis (OA) in dogs. This marked the first approval of a monoclonal antibody (mAb) for use in dogs by the FDA. Additionally, in June 2023, the FDA approved oclacitinib chewable tablets (Apoquel Chewable; Zoetis) for managing pruritus related to allergic dermatitis and atopic dermatitis in dogs aged one year or older. This chewable tablet is the first treatment available in the US specifically for controlling allergic itch and inflammation in dogs. Both of these veterinary medications are now available by prescription from veterinarians in the US.

North America Veterinary Healthcare Market Company Profiles

Some of the key players operating in the market include Merck & Co., Inc., Boehringer Ingelheim International GmbH, Ceva Santé Animale, Zoetis Inc, Elanco Animal Health Inc, Idexx Laboratories Inc, Neogen Corp, HIPRA SA, Shenzhen Mindray Animal Medical Technology Co., LTD, and Antech Diagnostics, Inc.

These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

North America Veterinary Healthcare Market Research Methodology

The following methodology has been followed for the collection and analysis of data presented in this report:

Secondary Research

The research process begins with comprehensive secondary research, utilizing internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

• Company websites, annual reports, financial statements, broker analyses, and investor presentations
• Industry trade journals and other relevant publications
• Government documents, statistical databases, and market reports
• News articles, press releases, and webcasts specific to companies operating in the market

Note:

All financial data included in the Company Profiles section has been standardized to US$. For companies reporting in other currencies, figures have been converted to US$ using the relevant exchange rates for the corresponding year.

Primary Research

The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis and gain valuable insights. These research interviews are designed to:

• Validate and refine findings from secondary research
• Enhance the expertise and market understanding of the analysis team
• Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects

Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

• Industry stakeholders: Vice Presidents, Business Development Managers, Market Intelligence Managers, and National Sales Managers
• External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise